Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses vWF-Gp IB interactions

Biorheology

Volumn 33, Issue 3, 1996, Pages 209-229

  Wagner, C T ^a   Kroll, M H ^b   Chow, T W ^a   Hellums, J D ^a   Schafer, A I ^b,c  

^a RICE UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Ephedrine; exercise; glycoprotein; platelet; shear stress

Indexed keywords

ADRENALIN; CREATINE PHOSPHATE; GLYCOPROTEIN; MONOCLONAL ANTIBODY; VON WILLEBRAND FACTOR; YOHIMBINE;

ANTIBODY RESPONSE; ARTERY DISEASE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CITRIC ACID CYCLE; COMPETITIVE INHIBITION; HUMAN; HUMAN CELL; PROTEIN PROTEIN INTERACTION; SCAVENGING SYSTEM; SHEAR STRESS; STIMULUS RESPONSE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 0029810721     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-355X(96)00018-2     Document Type: Article

References (66)

1. ARDLIE, H.G., McGUINESS, J.A. and GARRETT, J. (1985). Effect on human platelets of catecholamines at levels achieved in the circulation. Atherosclerosis 58, 251.
2. BACK, L.D., RADBILL, J.R. and CRAWFORD, D.W. (1977). Analysis of pulsatile, viscous blood flow through diseased coronary arteries of man. J. Biomech. 10, 339-353.
3. BELVAL, T., HELLUMS, J.D. and SOLIS, R.T. (1984). The kinetics of platelet aggregation induced by fluid-shearing stress. Microvasc. Res. 28, 279-288.
4. BORN, G.V.R. (1962). Quantitative investigations into the aggregation of blood platelets. J. Physiol. 162, 67-68P.
5. CHOW, T.W., HELLUMS, J.D., MOAKE, J.L., and KROLL, M.H. (1992). Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation. Blood 80, 113-120.
6. CHOW, T.W., WAGNER, C.T., MCCRARY, J.K., HELLUMS, J.D., and KROLL, M.H. Epinephrine potentiates the interaction between von Willebrand Factor and platelet membrane glycoprotein Ib. Submitted for publication.
7. COLLER, B.S., FOLTS, J.D., SMITH, S.R., SCUDDER, L.E., and JORDAN, R. (1989). Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Circulation 80, 1766-1774.
8. COLLER, B.S., PEERSCHKE, E.I., SCUDDER, L.E., and SULLIVAN, C.A. (1983a). A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J. Clin. Invest. 72, 325-338.
9. COLLER, B.S., PEERSCHKE, E.I., SCUDDER, L.E., and SULLIVAN, C.A. (1983b). Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: Additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 61, 99-110.
10. DAVIES, M.J., THOMAS, A.C., KNAPMAN, P.A., and HANGARTNER, J.R. (1986). Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 73, 418-427.
11. ELAYAN, H., KENNEDY, B.P. and ZIEGLER, M.G. (1990). Cardiac atria and ventricles contain different inducible adrenaline synthesizing enzymes. Cardiovasc. Res. 24, 53-56.
12. FALK, E. (1985). Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death. Circulation 71, 699-708.
13. FOLTS, J.D., GALLAGHER, K. and ROWE, G.G. (1982). Blood flow reductions in stenosed canine coronary arteries: Vasospasm of platelet aggregation? Circulation 65, 248-255.
14. FOLTS, J.D. and ROWE, G.G. (1988). Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries. Thromb. Res. 50, 507-516.
15. FUSTER, V., STEELE, P.M. and CHESEBRO, J.H. (1985). Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death. J. Am. Coll. Cardiol. 5, 175B-184B.
16. GIORGIO, T.D. and HELLUMS, J.D. (1988). A cone and plate viscometer for the continuous measurement of blood platelet activation. Biorheology 25, 605-624.
17. GODING, J.W. (1986). Monoclonal Antibodies: Principles and Practice. Academic Press, Orlando, Florida. 241 pp.
18. GOLDSMITH, H.L. and TURITTO, V.T. (1986). Rheological aspects of thrombosis and haemostasis: Basic principles and applications. Thrombos. Haemostas. 55, 415-435.
19. GOLDSTEIN, D.S. (1986). Sample handling and preparation for liquid chromatography and electrochemical assays for plasma catecholamines. In: Quantitative Analysis of Catecholamines and Related Compounds. A.M. Krstulovic, Eds., Ellis Horwood Limited, Chichester, England, pp. 126-136.
20. GOTO, S., IKEDA, Y., MURATA, M., HANDA, M., TAKAHASHI, E., YOSHIOKA, A., FUJIMURA, Y., FUKUYAMA, M., HANDA, S., and OGAWA, S. (1992). Epinephrine augments von Willebrand Factor-dependent shear-induced platelet aggregation. Circulation 86, 1859-1863.
21. r 6,400 aurin tricarboxylic acid directly activates platelets. Thromb. Res. 71, 77-88.
22. 2 and theophylline on the response of platelets subjected to shear stress. Blood 58, 678-681.
23. HELLUMS, J.D. and HARDWICK, R.A. (1981). Response of platelets to shear stress - a review. In: Hemovascular Rheology: The Physics of Blood and Vascular Tissue. N.H.C. Hwang and D.R. Gross, Eds., Sijthoff and Noorhoff, Amsterdam, Netherlands, pp. 160-183.
24. HELLUMS, J.D., PETERSON, D.M., STATHOPOULOS, N.A., MOAKE, J.L., and GIORGIO, T.D. (1987). Studies on the mechanisms of shear-induced platelet activation. In: Cerebral Ischemia and Hemorheology. A. Hartmann and W. Kuschinsky, Eds., Springer-Verlag, New York, New York, pp. 80-89.
25. HJEMDAHL, P. (1984). Catecholamine measurements by high-performance liquid chromatography. Am. J. Physiol. 247, E13-E20.
26. HJEMDAHL, P., CHRONOS, N.A.F., WILSON, D.J., BOULOUX, P., and GOODALL, A.H. (1994). Epinephrine sensitizes human platelets in vivo and in vitro as studied by fibrinogen binding and P-selectin expression. Arterioscler. Thromb. 14, 77-84.
27. HUANG, E.M. and DETWILER, T.C. (1981). Characteristics of the synergistic actions of platelet agonists. Blood 57, 685.
28. HUMPHRIES, J.E., YIRINEC, B.A. and HESS, C.E. (1992). Atherosclerosis and unstable angina in Bernard-Soulier syndrome. Am. J. Clin. Pathol. 97, 652-655.
29. IKEDA, Y., HANDA, M., KAMATA, T., KAWANO, K., KAWAI, Y., WATANABE, K., KAWAKAMI, K., SAKAI, K., FUKUYAMA, M., ITAGAKI, I., YOSHIOKA, A., and RUGGERI, Z.M. (1993). Transmembrane calcium influx associated with von Willebrand factor binding to GP Ib in the initiation of shear-induced platelet aggregation. Thrombos. Haemostas. 69, 496-502.
30. IKEDA, Y., HANDA, M., KAWANO, K., KAMATA, T., MURATA, M., ARAKI, Y., ANBO, H., KAWAI, Y., WATANABE, K., ITAGAKI, I., SAKAI, K., and RUGGERI, Z.M. (1991). The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J. Clin. Invest. 87, 1234-1240.
31. KERALY, C.L., KINLOUGH-RATHBONE, R.L., PACKHAM, M.A., SUZUKI, H., and MUSTARD, J.F. (1988). Conditions affecting the responses of human platelets to epinephrine. Thrombos. Haemostas. 60, 209-216.
32. KERRY, R. and SCRUTTON, M.C. (1985). Platelet adrenoceptors. In: The Platelets: Physiology and Pharmacology. G.L. Longenecker, Ed., Academic Press, San Diego, California, pp. 113-157.
33. KESTIN, A.S., ELLIS, P.A., BARNARD, M.R., ERRICHETTI, A., ROSNER, B.A., and MICHELSON, A.D. (1993). Effect of strenuous exercise on platelet activation state and reactivity. Circulation 88, 1502-1511.
34. KINLOUGH-RATHBONE, R.L. and MUSTARD, J.F. (1986). Synergism of agonists. In: Platelet Responses and Metabolism. Responses. H. Holmsen, Ed., CRC Press, Boca Raton, Florida, pp. 193-207.
35. KINLOUGH-RATHBONE, R.L. and PACKHAM, M.A. (1992). Unexpected effects of aurin tricarboxylic acid on human platelets. Thrombos. Haemostas. 68, 189-193.
36. KINLOUGH-RATHBONE, R.L., PACKHAM, M.A. and MUSTARD, J.F. (1977). Synergism between platelet aggregating agents: The role of the arachidonate pathway. Thromb. Res. 11, 567-580.
37. KONSTANTOPOULOS, K., WU, K.K., UDDEN, M.M., BAÑEZ, E.I., SHATTIL, S.J., and HELLUMS, J.D. (1995). Flow cytometric studies of platelet responses to shear stress in whole blood. Biorheology 32, 73-93.
38. KROLL, M.H., HARRIS, T.S., MOAKE, J.L., HANDIN, R.I., and SCHAFER, A.I. (1991). Von Willebrand factor binding to platelet GpIb initiates signals for platelet activation. J. Clin. Invest. 88, 1568-1573.
39. KROLL, M.H., HELLUMS, J.D., GUO, Z., DURANTE, W., RAZDAN, K., HRBOLICH, J.K., and SCHAFER, A.I. (1993). Protein kinase C is activated in platelets subjected to pathological shear stress. J. Biol. Chem. 268, 3520-3524.
40. KROLL, M.H. and SCHAFER, A.I. (1995). The analysis of ligand-receptor interactions in platelet activation. In: Immunophamacology of Platelets. M. Joseph, Ed., Academic Press, London, England, p. 31.
41. LANZA, F., BERETZ, A., STIERLÉ, A., HANAU, D., KUBINA, M., and CAZENAVE, J.-P. (1988). Epinephrine potentiates human platelet activation but is not an aggregation agent. Am. J. Physiol. 255, H1276-H1288.
42. LARSSON, P.T., WALLÉN, N.H. and HJEMDAHL, P. (1994). Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Circulation 89, 1951-1957.
43. MITTLEMAN, M.A., MACLURE, M., TOFLER, G.H., SHERWOOD, J.B., GOLDBERG, R.J., and MULLER, J.E. (1993). Triggering of acute myocardial infarction by heavy physical exertion. N. Engl. J. Med. 329, 1677-1683.
44. MOAKE, J.L., OLSON, J.D., TROLL, J.H., TANG, S.S., FUNICELLA, T. and PETERSON, D.M. (1980). Binding of radioiodinated human von Willebrand factor to Bernard-Soulier, thrombasthenic and von Willebrand's disease platelets. Thromb. Res. 19, 21-27.
45. MOAKE, J.L., TURNER, N.A., STATHOPOULOS, N.A., NOLASCO, L., and HELLUMS, J.D. (1988). Shear-induced platelet aggregation can be mediated by vWF released from platelets, as well as by exogenous large or unusually large multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood 71, 1366-1374.
46. MOAKE, J.L., TURNER, N.A., STATHOPOULOS, N.A., NOLASCO, L.H., and HELLUMS, J.D. (1986). Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation. J. Clin. Invest. 78, 1456-1461.
47. MULLER, J.E., STONE, P.H., TURI, Z.G., RUTHERFORD, J.D., CZEISLER, C.A., PARKER, C., POOLE, W.K., PASSAMANI, E., ROBERTS, R., ROBERTSON, T., SOBEL, B.E., WILLERSON, J.T., BRAUNWALD, E., and the MILIS Study Group. (1985). Circadian variation in the frequency of onset of acute myocardial infarction. N. Engl. J. Med. 313, 1315-1322.
48. O'BRIEN, J.R. (1964). A comparison of platelet aggregation produced by seven compounds and a comparison of their inhibitors. J. Clin. Pathol. 17, 275-281.
49. 2+ uptake in human blood platelets. Am. J. Physiol. 239, H483-H488.
50. PEDVIS, L.G., WONG, T. and FROJMOVIC, M.M. (1988). Differential inhibition of the platelet activation sequence: Shape change, micro- and macro- aggregation, by a stable prostacyclin analogue (iloprost). Thrombos. Haemostas. 59, 323-328.
51. PETERSON, D.M., STATHOPOULOS, N.A., GIORGIO, T.D., HELLUMS, J.D., and MOAKE, J.L. (1987). Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood 69, 625-628.
52. PHILLIPS, M.D., MOAKE, J.L., NOLASCO, L., and TURNER, N. (1988). Aurin tricarboxylic acid: a novel inhibitor of the association of von Willebrand factor and platelets. Blood 72, 1898-1903.
53. PLOW, E.F. and MARGUERIE, G.A. (1980). Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP. J. Biol. Chem. 255, 10971-10977.
54. RAO, G.H.R., JOHNSON, G.J. and WHITE, J.G. (1980). Influence of epinephrine on the aggregation response of aspirin-treated platelets. Protaglandins Med. 5, 45-58.
55. RAO, G.H.R. and WHITE, J.G. (1981). Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets. Am. J. Hematol. 11, 355-366.
56. RAZDAN, K., HELLUMS, J.D. and KROLL, M.H. (1994). Shear stress-induced von Willebrand factor binding to platelets causes the activation of tyrosine kinase(s). Biochem. J. 302, 681-686.
57. ROUX, S.P., SAKARIASSEN, K.S., TURITTO, V.T., and BAUMGARTNER, H.R. (1991). Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. Arterioscler. Thromb. 11, 1182-1191.
58. SANTOS, M.T., VALLES, J., MARCUS, A.J., SAFIER, L.B., BROEKMAN, M.J., ISLAM, N., ULLMAN, ILL., EIROA, A.M. and AZNAR, J. (1991). Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J. Clin. Invest. 87, 571-580.
59. SHATTIL, S.J., MOTULSKY, H.J., INSEL, P.A., FLAHERTY, L., and BRASS, L.F. (1986). Expression of fibrinogen receptors during activation and subsequent desensitization of human platelets by epinephrine. Blood 68, 1224-1231.
60. 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Thrombos. Haemostas. 70, 506-513.
61. STRONY, J., PHILLIPS, M., BRANDS, D., MOAKE, J., and ADELMAN, B. (1990). Aurin tricarboxylic acid in a canine model of coronary artery thrombosis. Circulation 81, 1106-14.
62. TOFLER, G.H., BREZINSKI, D., SCHAFER, A.I., CZEISLER, C.A., RUTHERFORD, J.D., WILLICH, S.N., GLEASON, R.E., WILLIAMS, G.H., and MULLER, J.E. (1987). Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N. Engl. J. Med. 316, 1514-1518.
63. TURITTO, V.T. (1982). Blood viscosity, mass transport, and thrombogenesis. Prog. Hemost. Thromb. 6, 139-177.
64. WARE, J. A., SMITH, M. and SALZMAN, E. W. (1987). Synergism of platelet-aggregating agents: Role of elevation of cytoplasmic calcium. J. Clin. Invest. 80, 267-271.
65. WEISS, H.J., HAWIGER, J., RUGGERI, Z.M., TURITTO, V.T., THIAGARAJAN, P. and HOFFMANN, T. (1989). Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by glycoprotein IIb-IIIa complex at high shear rate. J. Clin. Invest. 83, 288-297.
66. WILLICH, S.N., LEWIS, M., LÖWEL, H., ARNTZ, H.-R., SCHUBERT, F., and SCHRÖDER, R. (1993). Physical exertion as a trigger of acute myocardial infarction. N. Engl. J. Med. 329, 1684-1690.